22/10/2014 21:43:16 Free Membership Login

Watson News (NYSE:WPI)

DateTimeSource
Headline
01/29/201311:24AMZACKSMedTech Industry Stock Outlook - Jan 2013 - Industry Outlook
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the worldwide medical devices market. The US still holds the leading position with almost one-third of the market share. However, emerging economies like Brazil, Russia, India and China – collectively known... More...>>
01/24/20139:00AMPRNUSWatson Pharmaceuticals, Inc. is Now Actavis, Inc.
Watson Pharmaceuticals, Inc. is Now Actavis, Inc. /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:0.62em; font-family:"Arial"; color:black; margin:"0in"; } Watson... More...>>
01/23/20139:29AMPRNUSWatson Confirms Opana® ER Patent Challenge
Watson Confirms Opana® ER Patent Challenge /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:0.62em; font-family:"Arial"; color:black; margin:"0in"; } Watson Confirms... More...>>
01/23/20137:30AMPRNUSWatson Acquires Uteron Pharma SA
Watson Acquires Uteron Pharma SA /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:0.62em; font-family:"Arial"; color:black; margin:"0in"; } Watson Acquires Uteron... More...>>
01/22/201311:30AMZACKSCanada Approves Forest's Bystolic - Analyst Blog
Forest Laboratories, Inc. (FRX) recently announced the Canadian approval of its hypertension treatment, Bystolic (nebivolol). The company expects to launch Bystolic, a long-acting, cardio-selective beta-blocker, in Canada in the second quarter of calendar 2013. Bystolic, which is already approved and marketed in the US... More...>>
01/18/20138:00AMPRNUSToday's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy
Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy PR Newswire LONDON, January 18, 2013 LONDON, January 18, 2013 /PRNewswire/ -- The patent cliff has seen many drug majors lose... More...>>
01/18/20138:00AMPRNUSToday's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy
Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy PR Newswire LONDON, January 18, 2013 LONDON, January 18, 2013 /PRNewswire/ -- The patent cliff has seen many drug majors lose... More...>>
01/11/20139:15AMPRNUSWatson To Host 2013 Investor Meeting January 25 In New York
Watson To Host 2013 Investor Meeting January 25 In New York /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:0.62em; font-family:"Arial"; color:black; margin:"0in";... More...>>
01/09/201312:00PMZACKSForest Settles with Glenmark - Analyst Blog
Forest Laboratories, Inc. (FRX) recently entered into a settlement agreement with Glenmark Pharmaceuticals Ltd., relating to its patent infringement litigation for Bystolic (nebivolol). Glenmark was looking to launch its generic version of Bystolic. Under the terms of the settlement agreement, Forest Labs will provide... More...>>
01/08/20134:36AMZACKSStock Market News for January 8, 2013 - Market News
Investor apprehensions surrounding fourth-quarter earnings dragged benchmarks into negative territory on Monday. Indices declined after posting a strong rally in the previous week, during which the S&P 500 had reached its highest level in nearly five years. Alcoa will kick off the fourth-quarter earning season after... More...>>
01/07/20139:52AMZACKSImpax Launches Opana ER Generic - Analyst Blog
Global Pharmaceuticals, the generic division of Impax Laboratories, Inc. (IPXL), a specialty pharmaceutical company, recently started shipping its generic version of Endo Health Solutions’ (ENDP) Opana ER (oxymorphone hydrochloride). Opana ER is approved for relief from moderate to severe acute pain in patients who... More...>>
01/07/20136:00AMZACKSWatson's Generic Product Approved - Analyst Blog
Watson Pharmaceuticals, Inc. (WPI) recently announced that it gained US Food and Drug Administration (FDA) approval for its generic version of Ferring Pharmaceuticals' Lysteda (tranexamic acid) tablet. The company intends to launch the product soon. Lysteda tablet is approved for the treatment of cyclic heavy menstrual... More...>>
01/04/20131:21PMZACKSTough Times Ahead for Endo Health - Analyst Blog
Endo Health Solutions (ENDP) recently issued a disappointing outlook for 2013. The US-based diversified healthcare company expects adjusted earnings per share for 2013 in the range of $4.40 -$4.70 per share. The guidance range is significantly below the Zacks Consensus Estimate of $5.02 per share. The company expects to... More...>>
01/04/20131:17PMZACKSPatent Challenge for Auxilium Pharma - Analyst Blog
Auxilium Pharmaceuticals, Inc. (AUXL) and Xstelos Holdings, Inc. (XTLS) recently received a notice from Upsher-Smith Laboratories, Inc. regarding the filing of  a 505(b)(2) new drug application (NDA) for Auxilium Pharma’s 1% testosterone gel, Testim. The 505(b)(2) NDA contains a paragraph IV certification under... More...>>
01/03/20139:00AMPRNUSWatson's Generic Lysteda® Receives FDA Approval
Watson's Generic Lysteda® Receives FDA Approval /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:8pt; font-family:"Arial"; color:black; } Watson's Generic... More...>>
01/02/20135:00AMZACKSWatson Files Velcade ANDA - Analyst Blog
Watson Pharmaceuticals, Inc. (WPI) recently announced that it is seeking FDA approval for its generic version of Millennium Pharma’s Velcade (bortezomib). Millennium Pharma is a wholly-owned subsidiary of Takeda Pharma (TKPYY). The abbreviated new drug application (ANDA) was filed by Actavis, Inc. Actavis was acquired... More...>>
12/28/20129:00AMPRNUSWatson Confirms Velcade® Patent Challenge
Watson Confirms Velcade® Patent Challenge /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:8pt; font-family:"Arial"; color:black; } Watson Confirms Velcade®... More...>>
12/28/20128:33AMPRNUSEmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals
EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals PR Newswire MIAMI, December 28, 2012 MIAMI, December 28, 2012 /PRNewswire/ -- EmergingGrowth.com, a leading... More...>>
12/28/20128:33AMPRNUSEmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals
EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals PR Newswire MIAMI, December 28, 2012 MIAMI, December 28, 2012 /PRNewswire/ -- EmergingGrowth.com, a leading... More...>>
12/26/20129:28AMMWUSLYB, WPI, SSYS and HW Freshly Hit a New 52-Week High
Wall Street Active pro-traders will be assisting investors today on LYB, WPI, SSYS and HW, and provide insight based on their extensive experience so that you can boost your stock portfolio on the short-term or the long-term. If you are a shareholder in any of these companies do not miss this once in a life time opportunity... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nyse wpi141022 21:43